1. Home
  2. STAA vs ATUS Comparison

STAA vs ATUS Comparison

Compare STAA & ATUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • ATUS
  • Stock Information
  • Founded
  • STAA 1982
  • ATUS 2015
  • Country
  • STAA United States
  • ATUS United States
  • Employees
  • STAA N/A
  • ATUS N/A
  • Industry
  • STAA Ophthalmic Goods
  • ATUS Cable & Other Pay Television Services
  • Sector
  • STAA Health Care
  • ATUS Telecommunications
  • Exchange
  • STAA Nasdaq
  • ATUS Nasdaq
  • Market Cap
  • STAA 1.2B
  • ATUS 1.2B
  • IPO Year
  • STAA N/A
  • ATUS 2017
  • Fundamental
  • Price
  • STAA $23.49
  • ATUS $2.70
  • Analyst Decision
  • STAA Buy
  • ATUS Hold
  • Analyst Count
  • STAA 7
  • ATUS 10
  • Target Price
  • STAA $42.83
  • ATUS $2.39
  • AVG Volume (30 Days)
  • STAA 701.0K
  • ATUS 3.3M
  • Earning Date
  • STAA 02-19-2025
  • ATUS 02-13-2025
  • Dividend Yield
  • STAA N/A
  • ATUS N/A
  • EPS Growth
  • STAA 9.97
  • ATUS N/A
  • EPS
  • STAA 0.44
  • ATUS N/A
  • Revenue
  • STAA $341,224,000.00
  • ATUS $9,021,002,000.00
  • Revenue This Year
  • STAA $8.37
  • ATUS N/A
  • Revenue Next Year
  • STAA $10.55
  • ATUS N/A
  • P/E Ratio
  • STAA $52.79
  • ATUS N/A
  • Revenue Growth
  • STAA 10.01
  • ATUS N/A
  • 52 Week Low
  • STAA $21.13
  • ATUS $1.52
  • 52 Week High
  • STAA $52.68
  • ATUS $3.18
  • Technical
  • Relative Strength Index (RSI)
  • STAA 44.66
  • ATUS 51.48
  • Support Level
  • STAA $22.49
  • ATUS $2.63
  • Resistance Level
  • STAA $24.50
  • ATUS $2.95
  • Average True Range (ATR)
  • STAA 0.96
  • ATUS 0.15
  • MACD
  • STAA 0.15
  • ATUS -0.01
  • Stochastic Oscillator
  • STAA 50.24
  • ATUS 27.36

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

About ATUS Altice USA Inc.

Altice Europe acquired privately held us cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4 million U.S. homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York and i24News, a news operation focused on the Middle East.

Share on Social Networks: